• 1
    Sugimura T. Poly (adenosine diphosphate ribose). Prog Nucl Acid Res Mol Biol 1973; 13: 12751.
  • 2
    Masutani M, Nakagama H, Sugimura T. Poly(ADP-ribosyl)ation in relation to cancer and autoimmune disease. Cell Mol Life Sci 2005; 62: 76983.
  • 3
    Miwa M, Kanai M, Uchida M, Uchida K, Hanai S. Roles of poly(ADP-ribose) metabolism in the regulation of centrosome duplication and in the maintenance of neuronal integrity. In: BuerkleA, ed. Poly(ADP-Ribosyl)ation. Georgetown, Texas: Landes Bioscience, 2006: 5160
  • 4
    Miwa M, Saikawa N, Yamaizumi Z, Nishimura S, Sugimura T. Structure of poly(adenosine diphosphate ribose): identification of 2′-[1″-ribosyl-2″-(or 3″-) (1″′-ribosyl) ]adenosine-5′,5″,5″′-tris (phosphate) as a branch linkage. Proc Natl Acad Sci USA 1979; 76: 5959.
  • 5
    Althaus FR, Richter C. ADP-ribosylation of proteins. Enzymology and biological significance. Mol Biol Biochem Biophys 1987; 37: 1237.
  • 6
    Hayashi K, Tanaka M, Shimada T, Miwa M, Sugimura T. Size and shape of poly(ADP-ribose): examination by gel filtration, gel electrophoresis and electron microscopy. Biochem Biophys Res Commun 1983; 112: 1027.
  • 7
    Schreiber V, Dantzer F, Ame JC, De Murcia G. Poly(ADP-ribose): novel functions for an old molecule. Nat Rev Mol Cell Biol 2006; 7: 51728.
  • 8
    Kanai M, Uchida M, Hanai S, Uematsu N, Uchida K, Miwa M. Poly(ADP-ribose) polymerase localizes to the centrosomes and chromosomes. Biochem Biophys Res Commun 2000; 278: 3859.
  • 9
    Ohashi S, Kanai M, Hanai S et al . Subcellular localization of poly(ADP-ribose) glycohydrolase in mammalian cells. Biochem Biophys Res Commun 2003; 307: 91521.
  • 10
    Morrison AR, Moss J, Stevens LA et al . ART2, A T cell surface mono-ADP-ribosyltransferase, generates extracellular poly(ADP-ribose). J Biol Chem 2006; 81: 33 36372.
  • 11
    Takamura-Enya T, Watanabe M, Totsuka Y et al . Mono (ADP-ribosyl)ation of 2′-deoxyguanosine residue in DNA by an apoptosis-inducing protein, pierisin-1, from cabbage butterfly. Proc Natl Acad Sci USA 2001; 98: 12 41419.
  • 12
    El-Khamisy SF, Masutani M, Suzuki H, Caldecott KW. A requirement for PARP-1 for the assembly or stability of XRCC1 nuclear foci at sites of oxidative DNA damage. Nucl Acids Res 2003; 31: 552633.
  • 13
    De Murcia JM, Niedergang C, Trucco C et al . Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc Natl Acad Sci USA 1997; 94: 73037.
  • 14
    Shibata A, Kamada N, Masumura K et al . Parp-1 deficiency causes an increase of deletion mutations and insertions/rearrangements in vivo after treatment with an alkylating agent. Oncogene 2005; 24: 132837.
  • 15
    Heale JT, Ball AR Jr, Schmiesing JA et al . Condensin I interacts with the PARP-1-XRCC1 complex and functions in DNA single-strand break repair. Mol Cell 2006; 21: 83748.
  • 16
    Malanga M, Althaus FR. Poly(ADP-ribose) reactivates stalled DNA topoisomerase I and induces DNA strand break resealing. J Biol Chem 2004; 279: 52448.
  • 17
    Von Kobbe C, Harrigan JA, May A et al . Central role for the Werner syndrome protein/poly(ADP-ribose) polymerase 1 complex in the poly (ADP-ribosyl) ation pathway after DNA damage. Mol Cell Biol 2003; 23: 860113.
  • 18
    Hochegger H, Dejsuphong D, Fukushima T et al . Parp-1 protects homologous recombination from interference by Ku and ligase IV in vertebrate cells. Embo J 2006; 25: 130514.
  • 19
    Bryant HE, Schultz N, Thomas HD et al . Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 2005; 434: 91317.
  • 20
    Farmer H, McCabe N, Lord CJ et al . Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 2005; 434: 91721.
  • 21
    Bryant HE, Helleday T. Inhibition of poly(ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair. Nucl Acids Res 2006; 34: 168591.
  • 22
    Menissier de Murcia J, Ricoul M, Tartier L et al . Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse. Embo J 2003; 22: 225563.
  • 23
    Oei SL, Ziegler M. ATP for the DNA ligation step in base excision repair is generated from poly(ADP-ribose). J Biol Chem 2000; 275: 23 2349.
  • 24
    Ame JC, De Murcia G. Regulation of PARG recruitment at DNA damage sites. Med Sci 2005; 11 (Suppl 1): 41.
  • 25
    Hassa PO, Haenni SS, Buerki C et al . Acetylation of poly(ADP-ribose) polymerase-1 by p300/CREB-binding protein regulates coactivation of NF-kappaB-dependent transcription. J Biol Chem 2005; 280: 40 45064.
  • 26
    Pavri R, Lewis B, Kim TK et al . PARP-1 determines specificity in a retinoid signaling pathway via direct modulation of mediator. Mol Cell 2005; 18: 8396.
  • 27
    Idogawa M, Masutani M, Shitashige M et al . Ku70 and poly(ADP-Ribose) Polymerase-1 competitively regulate {beta}-catenin and T-cell factor-4-mediated gene transactivation: possible linkage of DNA damage recognition and Wnt signaling. Cancer Res 2007; 67: 91118.
  • 28
    Kim MY, Mauro S, Gevry N, Lis JT, Kraus WL. NAD+-dependent modulation of chromatin structure and transcription by nucleosome binding properties of PARP-1. Cell 2004; 119: 80314.
  • 29
    Ju BG, Lunyak VV, Perissi V et al . A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription. Science 2006; 312: 1798802.
  • 30
    Tulin A, Spradling A. Chromatin loosening by poly(ADP)-ribose polymerase (PARP) at Drosophila puff loci. Science 2003; 299: 5602.
  • 31
    Zardo G, Caiafa P. The unmethylated state of CpG islands in mouse fibroblasts depends on the poly(ADP-ribosyl)ation process. J Biol Chem 1998; 273: 16 51720.
  • 32
    Pleschke JM, Kleczkowska HE, Strohm M, Althaus FR. Poly(ADP-ribose) binds to specific domains in DNA damage checkpoint proteins. J Biol Chem 2000; 275: 40 97480.
  • 33
    Yu W, Ginjala V, Pant V et al . Poly(ADP-ribosyl)ation regulates CTCF-dependent chromatin insulation. Nat Genet 2004; 36: 110510.
  • 34
    Karras GI, Kustatscher G, Buhecha HR et al . The macro domain is an ADP-ribose binding module. Embo J 2005; 24: 191120.
  • 35
    Shima H, Nakayasu M, Aonuma S, Sugimura T, Nagao M. Loss of the MYC gene amplified in human HL-60 cells after treatment with inhibitors of poly (ADP-ribose) polymerase or with dimethyl sulfoxide. Proc Natl Acad Sci USA 1989; 86: 74425.
  • 36
    Nozaki T, Masutani M, Watanabe M et al . Syncytiotrophoblastic giant cells in teratocarcinoma-like tumors derived from Parp-disrupted mouse embryonic stem cells. Proc Natl Acad Sci USA 1999; 96: 13 34550.
  • 37
    Nozaki T, Masutani M, Akagawa T, Sugimura T, Esumi H. Suppression of G1 arrest and enhancement of G2 arrest by inhibitors of poly(ADP-ribose) polymerase: possible involvement of poly(ADP-ribosyl)ation in cell cycle arrest following gamma-irradiation. Jpn J Cancer Res 1994; 85: 10948.
  • 38
    Watanabe F, Fukazawa H, Masutani M et al . Poly(ADP-ribose) polymerase-1 inhibits ATM kinase activity in DNA damage response. Biochem Biophys Res Commun 2004; 319: 596602.
  • 39
    Yu SW, Wang H, Poitras MF et al . Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 2002; 297: 25963.
  • 40
    Masutani M, Suzuki H, Kamada N et al . Poly(ADP-ribose) polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes. Proc Natl Acad Sci USA 1999; 96: 23014.
  • 41
    Yamagami T, Miwa A, Takasawa S, Yamamoto H, Okamoto H. Induction of rat pancreatic B-cell tumors by the combined administration of streptozotocin or alloxan and poly(adenosine diphosphate ribose) synthetase inhibitors. Cancer Res 1985; 45: 18459.
  • 42
    Cortes U, Tong WM, Coyle DL et al . Depletion of the 110-kilodalton isoform of poly(ADP-ribose) glycohydrolase increases sensitivity to genotoxic and endotoxic stress in mice. Mol Cell Biol 2004; 24: 716378.
  • 43
    Masutani M, Gunji A, Ogino H et al . Functional analysis of poly (ADP-ribose) glycohydrolase: Hypersensitivity to DNA damaging agents and spontaneous development of renal lesions under Parg-deficiency. Med Sci 2005; 11 (Suppl 1): 22.
  • 44
    Koh DW, Dawson TM, Dawson VL. Mediation of cell death by poly (ADP-ribose) polymerase-1. Pharmacol Res 2005; 52: 514.
  • 45
    Andrabi SA, Kim NS, Yu SW et al . Poly(ADP-ribose) (PAR) polymer is a death signal. Proc Natl Acad Sci USA 2006; 103: 18 30813.
  • 46
    Hanai S, Kanai M, Ohashi S et al . Loss of poly(ADP-ribose) glycohydrolase causes progressive neurodegeneration in Drosophila melanogaster. Proc Natl Acad Sci USA 2004; 101: 826.
  • 47
    Kanai M, Tong WM, Sugihara E, Wang ZQ, Fukasawa K, Miwa M. Involvement of poly(ADP-Ribose) polymerase 1 and poly (ADP-Ribosyl)ation in regulation of centrosome function. Mol Cell Biol 2003; 23: 245162.
  • 48
    Kun E, Kirsten E, Milo GE, Kurian P, Kumari HL. Cell cycle-dependent intervention by benzamide of carcinogen-induced neoplastic transformation and in vitro poly(ADP-ribosyl)ation of nuclear proteins in human fibroblasts. Proc Natl Acad Sci USA 1983; 80: 721923.
  • 49
    Yu M, Schreek S, Cerni C et al . PARP-10, a novel Myc-interacting protein with poly(ADP-ribose) polymerase activity, inhibits transformation. Oncogene 2005; 24: 198293.
  • 50
    Tsutsumi M, Masutani M, Nozaki T et al . Increased susceptibility of poly (ADP-ribose) polymerase-1 knockout mice to nitrosamine carcinogenicity. Carcinogenesis 2001; 22: 13.
  • 51
    Ogawa K, Masutani M, Kato K et al . Parp-1 deficiency does not enhance liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f]quinoline in mice. Cancer Lett 2006; 236: 328.
  • 52
    Gunji A, Uemura A, Tsutsumi M et al . Parp-1 deficiency does not increase the frequency of tumors in the oral cavity and esophagus of ICR/129Sv mice by 4-nitroquinoline 1-oxide, a carcinogen producing bulky adducts. Cancer Lett 2006; 241: 8792.
  • 53
    Tong WM, Ohgaki H, Huang H, Granier C, Kleihues P, Wang ZQ. Null mutation of DNA strand break-binding molecule poly(ADP-ribose) polymerase causes medulloblastomas in p53(-/-) mice. Am J Pathol 2003; 162: 34352.
  • 54
    Morrison C, Smith GC, Stingl L, Jackson SP, Wagner EF, Wang ZQ. Genetic interaction between PARP and DNA-PK in V (D) J recombination and tumorigenesis. Nat Genet 1997; 17: 47982.
  • 55
    Tong WM, Cortes U, Hande MP et al . Synergistic role of Ku80 and poly (ADP-ribose) polymerase in suppressing chromosomal aberrations and liver cancer formation. Cancer Res 2002; 62: 69906.
  • 56
    Lebel M, Lavoie J, Gaudreault I, Bronsard M, Drouin R. Genetic cooperation between the Werner syndrome protein and poly(ADP-ribose) polymerase-1 in preventing chromatid breaks, complex chromosomal rearrangements, and cancer in mice. Am J Pathol 2003; 162: 155969.
  • 57
    Raval-Fernandes S, Kickhoefer VA, Kitchen C, Rome LH. Increased susceptibility of vault poly(ADP-ribose) polymerase-deficient mice to carcinogen-induced tumorigenesis. Cancer Res 2005; 65: 884652.
  • 58
    Bieche I, De Murcia G, Lidereau R. Poly(ADP-ribose) polymerase gene expression status and genomic instability in human breast cancer. Clin Cancer Res 1996; 2: 11637.
  • 59
    Shiokawa M, Masutani M, Fujihara H et al . Genetic alteration of poly(ADP-ribose) polymerase-1 in human germ cell tumors. Jpn J Clin Oncol 2005; 35: 97102.
  • 60
    Lockett KL, Hall MC, Xu J et al . The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function. Cancer Res 2004; 64: 63448.
  • 61
    Hao B, Wang H, Zhou K et al . Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma. Cancer Res 2004; 64: 437884.
  • 62
    Zhang X, Miao X, Liang G et al . Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer. Cancer Res 2005; 65: 7226.
  • 63
    Sakiyama T, Kohno T, Mimaki S et al . Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer risk. Int J Cancer 2005; 114: 7307.
  • 64
    Aguiar RC, Yakushijin Y, Kharbanda S, Salgia R, Fletcher JA, Shipp MA. BAL is a novel risk-related gene in diffuse large B-cell lymphomas that enhances cellular migration. Blood 2000; 96: 432834.
  • 65
    Durkacz BW, Omidiji O, Gray DA, Shall S. (ADP-ribose)n participates in DNA excision repair. Nature 1980; 283: 5936.
  • 66
    Kawamitsu H, Miwa M, Tanaka Y et al . Inhibitors of poly(adenosine diphosphate ribose) polymerase potentiate the antitumor activity of bleomycin against Ehrlich ascites carcinoma. J Pharmacobiodyn 1982; 5: 9004.
  • 67
    Calabrese CR, Almassy R, Barton S et al . Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361. J Natl Cancer Inst 2004; 96: 5667.
  • 68
    Gallmeier E, Kern SE. Absence of specific cell killing of the BRCA2-deficient human cancer cell line CAPAN1 by poly(ADP-ribose) polymerase inhibition. Cancer Biol Ther 2005; 4: 7036.
  • 69
    Seimiya H, Muramatsu Y, Ohishi T, Tsuruo T. Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics. Cancer Cell 2005; 7: 2537.
  • 70
    Tentori L, Leonetti C, Scarsella M et al . Poly(ADP-ribose) glycohydrolase inhibitor as chemosensitiser of malignant melanoma for temozolomide. Eur J Cancer 2005; 41: 294857.
  • 71
    Kirkland JB. Niacin and carcinogenesis. Nutr Cancer 2003; 46: 11018.
  • 72
    Tashtoush BM, Qasem J, Williams JD, Dewald TP, Jacobson EL, Jacobson MK. Analysis and stability study of myristyl nicotinate in dermatological preparations by high-performance liquid chromatography. J Pharm Biomed Anal 2007; 43: 8939.